Huntington National Bank Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Huntington National Bank raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 277,377 shares of the medical equipment provider’s stock after purchasing an additional 10,806 shares during the period. Intuitive Surgical accounts for about 1.0% of Huntington National Bank’s portfolio, making the stock its 21st biggest position. Huntington National Bank owned about 0.08% of Intuitive Surgical worth $136,267,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Bouvel Investment Partners LLC grew its stake in Intuitive Surgical by 0.5% in the third quarter. Bouvel Investment Partners LLC now owns 13,950 shares of the medical equipment provider’s stock worth $6,853,000 after purchasing an additional 67 shares in the last quarter. Schrum Private Wealth Management LLC boosted its position in Intuitive Surgical by 6.6% during the 3rd quarter. Schrum Private Wealth Management LLC now owns 2,738 shares of the medical equipment provider’s stock valued at $1,345,000 after acquiring an additional 169 shares in the last quarter. ICICI Prudential Asset Management Co Ltd boosted its position in Intuitive Surgical by 19.0% during the 3rd quarter. ICICI Prudential Asset Management Co Ltd now owns 4,638 shares of the medical equipment provider’s stock valued at $2,279,000 after acquiring an additional 742 shares in the last quarter. Kovack Advisors Inc. boosted its position in Intuitive Surgical by 10.8% during the 3rd quarter. Kovack Advisors Inc. now owns 1,388 shares of the medical equipment provider’s stock valued at $682,000 after acquiring an additional 135 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its position in Intuitive Surgical by 2.0% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 56,155 shares of the medical equipment provider’s stock valued at $27,587,000 after acquiring an additional 1,122 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on ISRG shares. Mizuho increased their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. BTIG Research set a $535.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. Citigroup lifted their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Barclays raised their target price on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research report on Thursday, July 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Stock Down 0.1 %

NASDAQ ISRG opened at $536.69 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $287.98 and a 52-week high of $542.59. The stock has a market capitalization of $191.16 billion, a P/E ratio of 86.28, a P/E/G ratio of 5.28 and a beta of 1.39. The firm has a 50-day moving average price of $495.85 and a 200 day moving average price of $455.08.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares of the company’s stock, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the sale, the insider now directly owns 8,757 shares in the company, valued at $4,727,816.73. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 91,178 shares of company stock worth $45,897,071. 0.90% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.